介绍

本页面提供了有关 Gv 2019 Gp, L.l.c. 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Gv 2019 Gp, L.l.c.已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:VERV / Verve Therapeutics, Inc. 10% Owner 0
10% Owner 0
10% Owner 4,556,532
US:DBTX / Decibel Therapeutics Inc 10% Owner 0
如何解读这些图表

以下图表显示了在Gv 2019 Gp, L.l.c.进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

内幕交易历史

该表格显示了由 Gv 2019 Gp, L.l.c. 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2025-07-28 2025-07-25 4 VERV Verve Therapeutics, Inc.
Common Stock
U - Other -1,800,000 0 -100.00
2025-07-28 2025-07-25 4 VERV Verve Therapeutics, Inc.
Common Stock
U - Other -4,260,047 0 -100.00
2025-07-28 2025-07-25 4 VERV Verve Therapeutics, Inc.
Common Stock
U - Other -6,108,442 0 -100.00
2023-06-22 2023-06-21 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -19,003 0 -100.00 14.97 -284,496
2023-06-22 2023-06-21 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -19,003 10,100,058 -0.19
2023-06-22 2023-06-20 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -37,405 0 -100.00 15.06 -563,248
2023-06-22 2023-06-20 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -37,405 10,119,061 -0.37
2023-06-20 2023-06-16 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -6,532 0 -100.00 15.02 -98,109
2023-06-20 2023-06-16 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -6,532 10,156,466 -0.06
2023-06-20 2023-06-15 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -66,659 0 -100.00 14.92 -994,326
2023-06-20 2023-06-15 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -66,659 10,162,998 -0.65
2023-06-15 2023-06-14 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -28,960 0 -100.00 14.87 -430,684
2023-06-15 2023-06-14 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -28,960 10,229,657 -0.28
2023-06-15 2023-06-13 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -28,100 0 -100.00 15.13 -425,102
2023-06-15 2023-06-13 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -28,100 10,258,617 -0.27
2023-06-13 2023-06-12 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -16,031 0 -100.00 14.98 -240,151
2023-06-13 2023-06-12 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -16,031 10,286,717 -0.16
2023-06-13 2023-06-09 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -15,672 0 -100.00 14.48 -226,984
2023-06-13 2023-06-09 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -15,672 10,302,748 -0.15
2023-06-09 2023-06-08 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -5,000 0 -100.00 15.74 -78,686
2023-06-09 2023-06-08 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -5,000 10,318,420 -0.05
2023-06-09 2023-06-07 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -15,000 0 -100.00 16.92 -253,870
2023-06-09 2023-06-07 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -15,000 10,323,420 -0.15
2023-06-07 2023-06-06 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -29,975 0 -100.00 17.02 -510,166
2023-06-07 2023-06-06 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -29,975 10,338,420 -0.29
2023-06-07 2023-06-05 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -22,434 0 -100.00 16.70 -374,612
2023-06-07 2023-06-05 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -22,434 10,368,395 -0.22
2023-06-02 2023-06-01 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -471 0 -100.00 14.75 -6,949
2023-06-02 2023-06-01 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -44,752 471 -98.96 14.35 -642,245 6,759
2023-06-02 2023-06-01 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -45,223 10,390,829 -0.43
2023-06-02 2023-05-31 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -16,633 0 -100.00 13.65 -227,004
2023-06-02 2023-05-31 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -16,633 10,436,052 -0.16
2023-05-31 2023-05-30 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -16,805 0 -100.00 13.70 -230,240
2023-05-31 2023-05-30 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -16,805 10,452,685 -0.16
2023-05-31 2023-05-26 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -12,602 0 -100.00 13.70 -172,603
2023-05-31 2023-05-26 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -12,602 10,469,490 -0.12
2023-05-26 2023-05-25 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -23,161 0 -100.00 13.38 -309,973
2023-05-26 2023-05-25 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -23,161 10,482,092 -0.22
2023-05-26 2023-05-24 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -7,900 0 -100.00 13.66 -107,920
2023-05-26 2023-05-24 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -7,900 10,505,253 -0.08
2023-05-24 2023-05-23 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -43,939 0 -100.00 14.74 -647,648
2023-05-24 2023-05-23 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -43,939 10,513,153 -0.42
2023-05-24 2023-05-22 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -87,922 0 -100.00 14.13 -1,242,092
2023-05-24 2023-05-22 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -87,922 10,557,092 -0.83
2023-05-22 2023-05-19 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -63,212 0 -100.00 13.88 -877,066
2023-05-22 2023-05-19 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -63,212 10,645,014 -0.59
2023-05-22 2023-05-18 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -14,022 0 -100.00 13.06 -183,171
2023-05-22 2023-05-18 4 PRME Prime Medicine, Inc.
Common Stock
J - Other X -14,022 10,708,226 -0.13
2023-05-22 2023-05-18 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -13,076 10,722,248 -0.12 13.01 -170,100 139,481,435
2023-05-18 2023-05-17 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -15,000 10,735,324 -0.14 12.77 -191,600 137,125,514
2023-05-18 2023-05-16 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -50,649 10,750,324 -0.47 12.59 -637,676 135,347,654
2023-05-16 2023-05-15 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -157,952 10,800,973 -1.44 12.74 -2,012,087 137,589,275
2023-05-16 2023-05-12 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -27,290 10,958,925 -0.25 12.72 -347,222 139,434,786
2023-05-12 2023-05-11 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -4,807 10,986,215 -0.04 13.79 -66,290 151,503,201
2023-05-12 2023-05-11 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -21,819 10,991,022 -0.20 12.98 -283,243 142,679,952
2023-05-12 2023-05-10 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -87,397 11,012,841 -0.79 14.03 -1,225,804 154,462,804
2023-05-10 2023-05-09 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -321,238 11,100,238 -2.81 14.08 -4,522,613 156,276,921
2023-05-10 2023-05-08 4 PRME Prime Medicine, Inc.
Common Stock
S - Sale X -100,772 11,421,476 -0.87 14.13 -1,423,727 161,364,897
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -243 4,260,047 -0.01 32.90 -7,995 140,155,546
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -650 4,260,290 -0.02 31.99 -20,794 136,288,807
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -47,690 4,260,940 -1.11 31.12 -1,484,017 132,591,931
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -47,690 4,260,940 -1.11 31.12 -1,484,017 132,591,931
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -242 0 -100.00 32.90 -7,962
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -651 242 -72.90 31.99 -20,826 7,742
2022-11-08 2022-11-04 4 VERV Verve Therapeutics, Inc.
Common Stock
J - Other -48,583 6,108,442 -0.79
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -1,755 4,308,630 -0.04 33.84 -59,384 145,792,406
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -1,755 4,308,630 -0.04 33.84 -59,384 145,792,406
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -25,534 4,310,385 -0.59 33.14 -846,156 142,839,262
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -22,279 4,335,919 -0.51 32.32 -719,957 140,117,390
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -22,279 4,335,919 -0.51 32.32 -719,957 140,117,390
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -25,535 1,755 -93.57 33.14 -846,189 58,158
2022-11-04 2022-11-03 4 VERV Verve Therapeutics, Inc.
Common Stock
J - Other -49,569 6,157,025 -0.80
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -8,930 4,358,198 -0.20 36.78 -328,401 160,272,731
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -8,930 4,358,198 -0.20 36.78 -328,401 160,272,731
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -10,372 4,367,128 -0.24 36.28 -376,282 158,433,290
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -10,372 4,367,128 -0.24 36.28 -376,282 158,433,290
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -9,350 4,377,500 -0.21 34.78 -325,150 152,229,314
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -9,349 19,302 -32.63 34.78 -325,115 671,235
2022-11-04 2022-11-02 4 VERV Verve Therapeutics, Inc.
Common Stock
J - Other -28,651 6,206,594 -0.46
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -260 4,386,850 -0.01 38.64 -10,046 169,501,304
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -260 4,386,850 -0.01 38.64 -10,046 169,501,304
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -2,377 4,387,110 -0.05 37.82 -89,901 165,924,887
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -2,377 4,387,110 -0.05 37.82 -89,901 165,924,887
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -29,326 4,389,487 -0.66 36.69 -1,075,906 161,040,621
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -29,326 4,389,487 -0.66 36.69 -1,075,906 161,040,621
2022-11-02 2022-11-01 4 VERV Verve Therapeutics, Inc.
Common Stock
J - Other -31,963 6,235,245 -0.51
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -88 4,418,813 0.00 40.64 -3,577 179,600,445
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -88 4,418,813 0.00 40.64 -3,577 179,600,445
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -6,601 4,418,901 -0.15 40.16 -265,076 177,449,366
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -6,601 4,418,901 -0.15 40.16 -265,076 177,449,366
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -23,275 4,425,502 -0.52 38.94 -906,403 172,343,209
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -23,732 4,448,777 -0.53 37.91 -899,588 168,635,786
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -23,732 4,448,777 -0.53 37.91 -899,588 168,635,786
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
S - Sale X -23,276 6,689 -77.68 38.94 -906,442 260,491
2022-11-02 2022-10-31 4 VERV Verve Therapeutics, Inc.
Common Stock
J - Other -53,697 6,267,208 -0.85
2022-10-26 2022-10-24 4 PRME Prime Medicine, Inc.
Common Stock
P - Purchase 800,000 11,522,248 7.46 17.00 13,600,000 195,878,216
2022-10-26 2022-10-24 4 PRME Prime Medicine, Inc.
Common Stock
C - Conversion 1,762,440 1,762,440
2022-10-26 2022-10-24 4 PRME Prime Medicine, Inc.
Common Stock
C - Conversion 10,722,248 10,722,248
2022-04-08 3/A IONQ IonQ, Inc.
Common Stock
4,556,532
2021-10-04 3 IONQ IonQ, Inc.
Common Stock
4,556,532
2021-06-22 2021-06-21 4 VERV Verve Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -4,104,416 0 -100.00
2021-06-22 2021-06-21 4 VERV Verve Therapeutics, Inc.
Series A-2 Preferred Stock
C - Conversion -37,308,792 0 -100.00
2021-06-22 2021-06-21 4 VERV Verve Therapeutics, Inc.
Common Stock
C - Conversion 443,265 4,472,509 11.00
2021-06-22 2021-06-21 4 VERV Verve Therapeutics, Inc.
Common Stock
C - Conversion 4,029,244 4,029,244
2021-02-17 2021-02-17 4 DBTX Decibel Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -4,344,048 0 -100.00
2021-02-17 2021-02-17 4 DBTX Decibel Therapeutics, Inc.
Common Stock
C - Conversion 819,631 819,631
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)